Successful Use of Homeopathy In Over 2.5 Million People Reported From Cuba
Posted on January 1, 2009 by homeopathyresource

A remarkable successful use of homeopathic prophylaxis was reported from a Cuban conference. Of course, the exact numbers and results are still to be published. Cuba has its own vaccine production and instead of using a conventional medical vaccine homeopathic remedies were distributed to prevent the usual Leptospirosis outbreak after tropical flooding. The results were phenomenally excellent!

The CDC describes Leptospirosis as:“Leptospirosis is a bacterial disease that affects humans and animals. It is caused by bacteria of the genus Leptospira. In humans it causes a wide range of symptoms, and some infected persons may have no symptoms at all. Symptoms of leptospirosis include high fever, severe headache, chills, muscle aches, and vomiting, and may include jaundice (yellow skin and eyes), red eyes, abdominal pain, diarrhea, or a rash. If the disease is not treated, the patient could develop kidney damage, meningitis (inflammation of the membrane around the brain and spinal cord), liver failure, and respiratory distress.”

Here is a report from an attendee of a recent conference in Cuba:

A historical and inspiring event took place 10-12 December 2008 in Havana Cuba that I had the honour to attend. There, the Carlos J Finlay Institute under the guidance of its director-general, Dra. Conception Campa Huergo and Dr. Gustavo Bravo and others hosted NOSODES 2008, an International Meeting on Homeoprophilaxis, Homeopathic Immunization and Nosodes against Epidemics.

Homeopaths from Cuba, S. America, Canada, Australia, UK, and Kenya (yours truly) made presentations on the wide varieties of successful disease prevention using homeopathy and more specifically, nosodes.

Each presentation was more amazing than the previous. All were very remarkable and notable in the field of research and science. Some of the topics included Childhood Disease Prevention, Homeopathic prophylaxis as an aspect of gov’tal programs, Nosodes Genus Epidemicus and Compexes, Homeoprophylaxis on Agronomy, Homeoprophylaxis on Veternary, Homeoprophylaxis in TB, Homeoprophylaxis in Chagas disease, Homeoprophylaxis in hepatitis, Homeoprophylaxis in Malaria (yours truly, again) and the list of presentations goes on.

(I am sorry for my lack of variety of adjectives for this email – “remarkable”, “awesome” and “amazing” will be repeated often because I have no other way to express my opinion of this conference)

THE PREVENTION OF EPIDEMIC LEPTOSPIROSIS IN CUBA
But none of these remarkable speakers, each presenting their amazing work in disease prevention and use of nosodes could not hold a candle to the historical accomplishment of the Cubans in their presentation of controlling the local endemic-epidemic disease of Leptospirosis.

Now, the Finlay Institute is primarily the Cuban research institute that produces allopathic vaccinations for their country. Since Cuba is outcasted by the USA government, they have come to depend on themselves for the making of medicines, health care programs, etc. And since the Cuba is not under the yoke of the international pharmaceutical juggernaut, they are not held back from adopting homeopathy and other alternative medicines wholeheartedly into their national health programmes. The Finlay director-general herself is very pro-homeopathy (not to mention, besides, a macrobiotic vegetarian).

To put it simply, what they presented is this:

Cuba goes through a yearly cycle of Leptospirosis epidemic, especially after the hurricanes flood the countryside and water pollution reaches its height. (Leptospirosis: infectious disease caused by the spirochaete Leptospira transmitted to humans from rats, giving jaundice and kidney damage. Can cause death)

Annually the population is exposed to the disease, most especially after hurricanes.

Until Aug 2007, the Finlay Institute (a part of the Ministry of Public Health, Cuba) has been distributing its own allopathic Lepto vaccination. August is the height of the hurricane season. Annually, many are left homeless, flooded out and under the stress of disaster situation. There is a sharp rise in the lepto epidemic.

The usual expectacy of infection even with allopathic vaccination would have been around a few thousands, with some deaths included.

Part of the reason for this is that the high cost of vaccination prevents putting but the most at-risk populations (ie children, pregnant women, elderly) on vaccination. The cost of such limited vaccination is about US$3,000.000.

But in Aug 2007, Finlay put approximately [2,500,000] people (yes! 5 million doses!) in 2 provinces on homoepathic nosode prophylaxis at the cost of about only US$ 200,000.

That figure represents the entire population of the 2 provinces. The prophylaxis consisted of 2 single doses about 2 weeks apart. Included in the dose was the Lepto nosode + some Bach flower remedies to address the mental distress of the disaster situation.

How very amazing it was to watch this presentation being made. Up to the point, the presenters were showing us graph after graph of the usual rise of the epidemic, year after year, even with the use of allopathic vaccination. Each year the graphs would edge higher and higher towards the year-end, reaching up to the thousands of infected.

But this time, within 2 weeks after Aug 2007, the rising lines literally dropped off the chart to ZERO-Ten infections only! Yes. Near-zero infections, zero deaths from leptospirosis after Aug 2007.  And in 2008, no deaths, infections less than 10 a month.

HISTORY MADE FOR HOMEOPATHY

This mass treatment of 2.5 million people with homeopathy, I don’t believe, has been done anywhere else in the world, not even in India, where homeopathy enjoys the shelter of the government.

And the awesome results of going from hundreds of infected to near-zero in the period of a few weeks, also is historical. My jaw dropped as I watched the graphs demonstrate their success.

The Cuban team readily admits that they have not invented anything new as far as homeopathic philosophy or application. They have simply followed what we homeopaths know to work. And since they have no pharmaceutical multi-nationals to stop them, they were able to do it on a massive scale unknown in the history of homeopathy.

What is remarkable is their application to such a large population, and its dramatic success, with full scientific verification. The results are incontrovertible and undeniable even by the most rabid of anti-homeopaths.

[This post was edited to show and correct that there were 5 million doses and to 2.5 million people]

Back to Top

Brewitt et al. 1999

Recent randomized, double-blinded, placebo-controlled clinical studies demonstrated and replicated positive benefits of homeopathic recombinant human growth hormone (Brewitt et al. 1999). The three differently designed studies showed that an oral chewable tablet of homeopathic growth hormone was clinically efficacious, safe, non-toxic and economically practical as a longevity medicine. Functional benefits included those on the physical, physiological and psychological levels.

Good biomarkers for aging include self-reported symptoms that impede the physical, psychological or emotional quality of life. Self-reported quality of life measures were evaluated in all three types of randomized, double-blinded, placebo-controlled studies conducted on homeopathic recombinant human growth hormone (HrhGH) (Brewitt et al. 1999). Healthy people ages 18-72 years of age were enrolled (n=162) for four to eight weeks in three different cities. Their exercise activity ranged from none to at least five times per week. In one city, no one knew the substance being evaluated. Blood chemistry, total weight, lean body mass and body shape measurements were objective parameters evaluated. Clinical efficacy was determined by statistical differences between chewable tablets of HrhGH and placebo that were self-administered three times/day.

Serum igf-1 levels

The study findings highlighted several significant observations relevant to longevity. First, baseline serum IGF-1 levels were, on average, lower than the mean average reference range in two of the three cities selected for study (P<0.0001). Neither age nor exercise lead to the normalization of serum IGF-1 levels, only HrHGH lead to normal raises in IGF-1. Three physicians who used exercise only to raise IGF-1 levels actually decreased by –28 ± 4% in their serum IGF-1 levels after the first 21 days of the study.

Oral administration of HrhGH reproducibly increased serum IGF-1 levels by +25 ± 14% after three weeks on a formula of 6X +12C and +21 ± 13% and +26 ± 10% on a formula of 6C + 100C +200C after three and four weeks, respectively. HrhGH was the single most important intervention raising serum-IGF-1 levels. Exercise without adequate nutrition decreased serum IGF-1 levels. While serum IGF-1 has been cited most as a reliable measure of hGH physiological activity, others do not include it as a reliable indicator (Ho and Veldhuis 1994)

Lean body mass

Maintenance of lean body mass is critical for longevity and quality of life functions since lean mass below 65% of ideal weight no longer supports life (Griffin et al. 1998). Lean mass includes muscle, bone, organ density, all of which deteriorate during the aging process and directly correlate with death. Lean body mass reproducibly increased 2.5 ± 1.2 lbs in three weeks on 6C +100C +200C HrhGH compared to no increase on placebo (P=0.05). Weight loss of -3.27 ± 0.6lbs occurred on the 6X +12C HrhGH formula and –2.07 ± 0.52 lbs occurred on the 6C + 100C +200C HrhGH formula compared to none on placebo (P<0.05). In addition to objectively measured gains in lean mass, subjects self-reported gains in arm and leg strength, endurance and appearance.

Substantiation of the body weight and lean mass changes occurred with measurable body shape changes. Upper arms, where lean mass is most observable, increased +0.30 ± 0.1 inch in three weeks compared to placebo (P<0.0001). Neither age nor gender affected this outcome, only HrhGH treatment. Hips, where fat mass is commonly observable, decreased –2.1 ± 0.50 inches/month on treatment compared to placebo (P<0.001).

Overall improvements

Twenty-five self-perceived symptoms were evaluated in all studies. HrhGH treatment groups showed significant improvements in those areas most specific to hGH target sites compared to placebo. For example, in terms of hormonal declines that affect hGH-target sites of skin, intestines, urogenital and lungs, subjects reported statistically significant improvements in terms of skin softness and moisture, easier breathing with less coughing and phlegm build-up, relief from intestinal pain and/or bloating. In terms of neurological and psychological improvements subject reported statistically significant relief from apathy, anxiety, anger, headaches, joint pain and/or edema. Sleep quality, length and depth also significantly improved.

Quality of life during aging means being able to complete the physical tasks necessary to carry out one’s functions. Subjects on HrhGH treatment reported statistically greater energy and endurance, increased libido and visual improvement compared to placebo. Thus, specific target sites for hGH in the body that can be self recognized for health symptoms such as lungs, skin, intestines, urogenital, heart function, eyes and brain were all reported as improved on homeopathic recombinant hGH versus placebo.

These short clinical studies demonstrate that intervention with a cell signaling treatment approach using oral chewable tablets of HrhGH provided statistically significant physiological and psychological benefits above placebo effects. While longer studies are necessary, the implications of these studies are that affordable and non-toxic options are available to people as preventative medicines.

 

References: 

Brewitt, Barbara Ph.D.Chapter 8.2 from The Advanced Guide to Longevity Medicine Published by IMPAKT Communications 3/31/01

Brewitt, B., Hughes, J., Welsh, E.A., Jackson, R. Homeopathic human growth hormone for physiologic and psychologic health. Alt. Compl. Ther. 1999 5(6):373-385

Griffin, G. E., Paton, N. I., Cofrancesco Jr., J., Arastéh, K., Bauer, G., Schwenk, A., Mauss, S., Mulligan, K. 1998 Nutrition and quality of life in HIV infection. The role of growth hormone in HIV-associated wasting. J. Clin. Res. 1:199-218

Ho, K.Y., Velduis, J.D. Diangosis of growth hormone deficiency in adults. Endocrinol. Metab. 1994 1(suppl. A):561-563

Semsei, I. On the nature of aging. Mech. Ageing Dev. 2000 117(1-3):93-108

Back to Top

Check back soon for more information on Bio-Plene™, XOOY™, Energized Natural Healing Clay and Balancing Gel!

We are udating this website daily!

Back to Top

The information presented on this website is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals.  This information is not intended to replace the advice of a doctor. Tri-Health Products disclaims any liability for the decisions you make based on this information.  The FDA has not approved or evaluated the statements contained in this website.  fat loss with hgh & cellular repair with hgh.  hGH,

© 2004 Tri-Health Products. © 2007 Tri-Health Products.© 2009 Tri-Health Products.All Rights Reserved.  ©The copyrighted information contained on these pages is the exclusive intellectual property of Tri-Health Products and may not be reproduced, copied, sold or otherwise disseminated without the expressed written consent of Tri-Health Products, and/ or its’ Principals.

Fair Use Statement

This page may contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in an effort to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. we believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law.

In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml

If you wish to use this copyrighted material for purposes of your own that go beyond ‘fair use’, you MUST obtain permission from the copyright owner.